Manu Hospital And Research Centre Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
- Paid Up Capital ₹ 7.50 M
- Company Age 34 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.06 Cr
- Revenue Growth 15.39%
- Profit Growth 58.28%
- Ebitda 12.38%
- Net Worth 9.62%
- Total Assets -5.82%
About Manu Hospital And Research Centre
Manu Hospital And Research Centre Private Limited (MHARCPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 28 February 1990 and has a history of 34 years and 11 months. Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 7.50 M.
The company has closed loans amounting to ₹1.06 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Shalini Agrawal and Atul Agrawal serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U85110DL1990PTC039356
- Company No.
039356
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Feb 1990
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Manu Hospital And Research Centre?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shalini Agrawal  | Director | 26-Jun-2006 | Current |
| Atul Agrawal | Director | 27-Jul-1996 | Current |
Financial Performance of Manu Hospital And Research Centre.
Manu Hospital And Research Centre Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 15.39% increase. The company also saw a substantial improvement in profitability, with a 58.28% increase in profit. The company's net worth moved up by a moderate rise of 9.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Manu Hospital And Research Centre?
In 2019, Manu Hospital And Research Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹1.06 Cr
Charges Breakdown by Lending Institutions
- State Bank Of India : 1.06 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Apr 2002 | State Bank Of India | ₹1.06 Cr | Satisfied |
How Many Employees Work at Manu Hospital And Research Centre?
Unlock and access historical data on people associated with Manu Hospital And Research Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Manu Hospital And Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Manu Hospital And Research Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
